| 000 | 01051nam a2200289 a 4500 | ||
|---|---|---|---|
| 008 | 970709s1996^^^^nyu^^^^^^b^^^^001^0^eng^c | ||
| 020 | _a0824797272 (encuadernado en tela : papel alcalino) | ||
| 035 | _aMX001000747625 | ||
| 040 |
_aDNLM/DLC _cDLC _dDLC |
||
| 041 | _aENG | ||
| 050 | 0 | 0 |
_aRM301.25 _bD78 1996 |
| 082 | 0 | 0 |
_a615/.19 _220 |
| 245 | 0 | 4 |
_aThe drug development process : _bincreasing efficiency and cost-effectiveness / _cedited by Peter G. Welling, Louis Lasagna, Umesh V. Banakar |
| 263 | _a9608 | ||
| 264 | 1 |
_aNew York : _bM. Dekker, _cc1996. |
|
| 300 | _a447 páginas | ||
| 336 |
_atexto _2rdacontent |
||
| 337 |
_asin medio _2rdamedia |
||
| 338 |
_avolumen _2rdacarrier |
||
| 490 | 0 |
_aDrugs and the pharmaceutical sciences ; _vv. 76 |
|
| 504 | _aIncluye referencias bibliograficas e indices. | ||
| 650 | 0 |
_aMedicamentos _xInvestigación |
|
| 650 | 0 | _aIndustria farmacéutica | |
| 700 | 1 |
_aWelling, Peter G., _eeditor |
|
| 700 | 1 |
_aLasagna, Louis, _d1923- , _eeditor |
|
| 700 | 1 |
_aBanakar, Umesh V., _d1956- , _eeditor |
|
| 999 |
_c1791 _d1791 |
||